Odyssean, LLC
CIK 0002092853 · DARIEN, CT · Quarter end: 2026-06-30 · Filed on: 2026-08-14 · Open the SEC source ↗
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.
$614.9M
2026 Q2
Positions
485
Top-10 ConcentrationHow much of the portfolio sits in the 10 largest holdings. High = concentrated bets.
6.0%
Est. Net Flow (Q)
—
2026 Q2
Top Holdings
RARE
ULTRAGENYX PHARMACEUTICAL IN
0.7%
KYMR
KYMERA THERAPEUTICS INC
0.6%
IDYA
IDEAYA BIOSCIENCES INC
0.6%
PCVX
VAXCYTE INC
0.6%
AFRM
AFFIRM HLDGS INC
0.6%
CLDX
CELLDEX THERAPEUTICS INC NEW
0.6%
LOAR
LOAR HOLDINGS INC
0.6%
MIRM
MIRUM PHARMACEUTICALS INC
0.6%
New / Increased
No prior quarter data
Reduced / Exited
No prior quarter data
Read the 2026-Q2 quarterly report · 13F Filing Calendar
13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.